Drug Profile
Testosterone topical - AbbVie
Alternative Names: ABT-SLV176Latest Information Update: 13 Nov 2021
Price :
$50
*
At a glance
- Originator AbbVie
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone agonists; Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hypogonadism
Most Recent Events
- 07 Sep 2016 No development reported - Clinical-Phase-Unknown for Hypogonadism in USA (Topical)
- 06 Mar 2014 Clinical trials in Hypogonadism in USA (Topical)
- 06 Mar 2014 AbbVie plans a phase III trial for Hypogonadism in USA (NCT02082197)